277 related articles for article (PubMed ID: 25583773)
1. Role of somatostatin analogues in the treatment of neuroendocrine tumors.
Narayanan S; Kunz PL
J Natl Compr Canc Netw; 2015 Jan; 13(1):109-17; quiz 117. PubMed ID: 25583773
[TBL] [Abstract][Full Text] [Related]
2. Role of Somatostatin Analogues in the Treatment of Neuroendocrine Tumors.
Narayanan S; Kunz PL
Hematol Oncol Clin North Am; 2016 Feb; 30(1):163-77. PubMed ID: 26614375
[TBL] [Abstract][Full Text] [Related]
3. When and How to Use Somatostatin Analogues.
de Herder WW
Endocrinol Metab Clin North Am; 2018 Sep; 47(3):549-555. PubMed ID: 30098715
[TBL] [Abstract][Full Text] [Related]
4. Somatostatin Analogues in the Treatment of Neuroendocrine Tumors: Past, Present and Future.
Stueven AK; Kayser A; Wetz C; Amthauer H; Wree A; Tacke F; Wiedenmann B; Roderburg C; Jann H
Int J Mol Sci; 2019 Jun; 20(12):. PubMed ID: 31234481
[TBL] [Abstract][Full Text] [Related]
5. Role of somatostatins in gastroenteropancreatic neuroendocrine tumor development and therapy.
Oberg KE; Reubi JC; Kwekkeboom DJ; Krenning EP
Gastroenterology; 2010 Sep; 139(3):742-53, 753.e1. PubMed ID: 20637207
[TBL] [Abstract][Full Text] [Related]
6. Consensus report on the use of somatostatin analogs for the management of neuroendocrine tumors of the gastroenteropancreatic system.
Oberg K; Kvols L; Caplin M; Delle Fave G; de Herder W; Rindi G; Ruszniewski P; Woltering EA; Wiedenmann B
Ann Oncol; 2004 Jun; 15(6):966-73. PubMed ID: 15151956
[TBL] [Abstract][Full Text] [Related]
7. Update on the management of neuroendocrine tumors: focus on somatostatin antitumor effects.
Gardner-Roehnelt NM
Clin J Oncol Nurs; 2012 Feb; 16(1):56-64. PubMed ID: 22297008
[TBL] [Abstract][Full Text] [Related]
8. Role of Somatostatin Analogues in Oncology. European Neuroendocrine Tumor Network (ENET). February 24-27, 2000, Innsbruck, Austria. Proceedings.
Digestion; 2000; 62 Suppl 1():1-108. PubMed ID: 11001649
[No Abstract] [Full Text] [Related]
9. Treatment of neuroendocrine tumors with somatostatin analogs.
Janson ET
Pituitary; 2006; 9(3):249-56. PubMed ID: 17001461
[TBL] [Abstract][Full Text] [Related]
10. Long-acting somatostatin analogues in the treatment of unresectable/metastatic neuroendocrine tumors.
Enzler T; Fojo T
Semin Oncol; 2017 Apr; 44(2):141-156. PubMed ID: 28923213
[TBL] [Abstract][Full Text] [Related]
11. Pasireotide in the treatment of neuroendocrine tumors: a review of the literature.
Vitale G; Dicitore A; Sciammarella C; Di Molfetta S; Rubino M; Faggiano A; Colao A
Endocr Relat Cancer; 2018 Jun; 25(6):R351-R364. PubMed ID: 29643113
[TBL] [Abstract][Full Text] [Related]
12. Biotherapies for GEP-NETs.
Öberg K
Best Pract Res Clin Gastroenterol; 2012 Dec; 26(6):833-41. PubMed ID: 23582922
[TBL] [Abstract][Full Text] [Related]
13. [Biotherapy of neuroendocrine tumours of the gastrointestinal tract and pancreas].
Hansen CP; Knigge U
Ugeskr Laeger; 2008 Jun; 170(24):2145-8. PubMed ID: 18565299
[TBL] [Abstract][Full Text] [Related]
14. [The somatostatin receptor family--a window against new diagnosis and therapy of cancer].
Hofsli E
Tidsskr Nor Laegeforen; 2002 Feb; 122(5):487-91. PubMed ID: 11961977
[TBL] [Abstract][Full Text] [Related]
15. Somatostatin Analogues in Neuroendocrine Tumors.
Kulke MH
J Natl Compr Canc Netw; 2016 Mar; 14(3):241-2. PubMed ID: 26957610
[No Abstract] [Full Text] [Related]
16. Octreotide and Lanreotide in Gastroenteropancreatic Neuroendocrine Tumors.
Pokuri VK; Fong MK; Iyer R
Curr Oncol Rep; 2016 Jan; 18(1):7. PubMed ID: 26743514
[TBL] [Abstract][Full Text] [Related]
17. [Efficacy of somatostatin analogues in the treatment of neuroendocrine tumours based on the results of recent clinical trials].
Igaz P
Orv Hetil; 2014 Nov; 155(48):1908-12. PubMed ID: 25417137
[TBL] [Abstract][Full Text] [Related]
18. The expanding role of somatostatin analogs in gastroenteropancreatic and lung neuroendocrine tumors.
Cives M; Strosberg J
Drugs; 2015 May; 75(8):847-58. PubMed ID: 25911185
[TBL] [Abstract][Full Text] [Related]
19. Neuroendocrine tumors--somatostatin receptor expression and somatostatin analog treatment.
Janson ET; Oberg K
Cancer Chemother Biol Response Modif; 2003; 21():535-46. PubMed ID: 15338762
[No Abstract] [Full Text] [Related]
20. Recent advances in the management of gastroenteropancreatic neuroendocrine tumors: insights from the 2017 ASCO Gastrointestinal Cancers Symposium.
Iyer R; Phan AT; Boudreaux JP
Clin Adv Hematol Oncol; 2017 Apr; 15 Suppl 4(4):1-24. PubMed ID: 28654022
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]